克拉黴素 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "克拉黴素" in Chinese language version.

refsWebsite

Global rank Chinese rank

16nih.gov

4^th place

5^th place

15doi.org

2^nd place

23^rd place

12web.archive.org

1^st place

4semanticscholar.org

11^th place

332^nd place

4archive.org

6^th place

4^th place

3books.google.com

3^rd place

8^th place

2drugs.com

399^th place

208^th place

2fda.gov

447^th place

581^st place

1europa.eu

68^th place

209^th place

1handle.net

102^nd place

492^nd place

1aasm.org

low place

1mayoclinic.org

1,610^th place

2,275^th place

1ed.ac.uk

1,871^st place

2,278^th place

1worldcat.org

5^th place

12^th place

aasm.org (Global: low place; Chinese: low place)

Treatment of Central Disorders of Hypersomnolence: An American Academy of Sleep Medicine Clinical Practice Guideline - Guidelines at a Glance (PDF). American Academy of Sleep Medicine. 2021 [2024-02-25]. （原始内容存档 (PDF)于2024-02-25）.

archive.org (Global: 6^th place; Chinese: 4^th place)

Tietz A, Heim MH, Eriksson U, Marsch S, Terracciano L, Krähenbühl S. Fulminant liver failure associated with clarithromycin. The Annals of Pharmacotherapy. January 2003, 37 (1): 57–60. PMID 12503933. doi:10.1345/1542-6270(2003)037<0057:flfawc>2.0.co;2.
Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, Garg AX. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. December 2013, 310 (23): 2544–53. PMID 24346990. doi:10.1001/jama.2013.282426.
Sekar VJ, Spinosa-Guzman S, De Paepe E, De Pauw M, Vangeneugden T, Lefebvre E, Hoetelmans RM. Darunavir/ritonavir pharmacokinetics following coadministration with clarithromycin in healthy volunteers. Journal of Clinical Pharmacology. January 2008, 48 (1): 60–5. PMID 18094220. S2CID 38368595. doi:10.1177/0091270007309706.
Polis MA, Piscitelli SC, Vogel S, Witebsky FG, Conville PS, Petty B, Kovacs JA, Davey RT, Walker RE, Falloon J, Metcalf JA, Craft C, Lane HC, Masur H. Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. August 1997, 41 (8): 1709–14. PMC 163990 . PMID 9257746. doi:10.1128/AAC.41.8.1709.

books.google.com (Global: 3^rd place; Chinese: 8^th place)

Greenwood D. Antimicrobial drugs : chronicle of a twentieth century medical triumph 1. Oxford: Oxford University Press. 2008: 239. ISBN 978-0-19-953484-5. （原始内容存档于2016-03-05）.
Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 498 [2025-01-06]. ISBN 978-3-527-60749-5. （原始内容存档于2024-09-29）.
Kirst HA. Macrolide Antibiotics 2. Basel: Birkhäuser Basel. 2012: 53. ISBN 978-3-0348-8105-0. （原始内容存档于2016-03-05）.

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Mommersteeg MC, Nieuwenburg SA, Wolters LM, Roovers BH, van Vuuren HA, Verhaar AP, Bruno MJ, Kuipers EJ, Peppelenbosch MP, Spaander MC, Fuhler GM. The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance.. United European Gastroenterol J. November 2023, 11 (9): e894–903. PMC 10637120 . PMID 37854002. doi:10.1002/ueg2.12473 .
Trotti LM, Becker LA, Friederich Murray C, Hoque R. Medications for daytime sleepiness in individuals with idiopathic hypersomnia. The Cochrane Database of Systematic Reviews. May 2021, 2021 (5): CD012714. PMC 8144933 . PMID 34031871. doi:10.1002/14651858.CD012714.pub2. There is insufficient evidence to conclude whether clarithromycin is effective for the treatment of idiopathic hypersomnia.
Maski K, Trotti LM, Kotagal S, Robert Auger R, Rowley JA, Hashmi SD, Watson NF. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. September 2021, 17 (9): 1881–1893. PMC 8636351 . PMID 34743789. doi:10.5664/jcsm.9328. Recommendation 9: We suggest that clinicians use clarithromycin (vs no treatment) for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL)
Winkel P, Hilden J, Fischer Hansen J, Hildebrandt P, Kastrup J, Kolmos HJ, Kjøller E, Jespersen CM, Gluud C, Jensen GB. Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?. Cardiology. 2011, 118 (1): 63–7. PMID 21447948. S2CID 11873791. doi:10.1159/000324533.
Tietz A, Heim MH, Eriksson U, Marsch S, Terracciano L, Krähenbühl S. Fulminant liver failure associated with clarithromycin. The Annals of Pharmacotherapy. January 2003, 37 (1): 57–60. PMID 12503933. doi:10.1345/1542-6270(2003)037<0057:flfawc>2.0.co;2.
Hougaard Christensen MM, Bruun Haastrup M, Øhlenschlaeger T, Esbech P, Arnspang Pedersen S, Bach Dunvald AC, Bjerregaard Stage T, Pilsgaard Henriksen D, Thestrup Pedersen AJ. Interaction potential between clarithromycin and individual statins-A systematic review. Basic Clin Pharmacol Toxicol. April 2020, 126 (4): 307–317. PMID 31628882. doi:10.1111/bcpt.13343.
Herdegen T, Cascorbi I. Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs: Recommendations for Clinical Practice. Dtsch Arztebl Int. December 2023, 120 (49): 833–840. PMC 10824494 . PMID 37874128. S2CID 264438050. doi:10.3238/arztebl.m2023.0223.
Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Annals of Internal Medicine. June 2013, 158 (12): 869–76. PMID 23778904. S2CID 21222679. doi:10.7326/0003-4819-158-12-201306180-00004.
Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, Garg AX. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. December 2013, 310 (23): 2544–53. PMID 24346990. doi:10.1001/jama.2013.282426.
Gélisse P, Hillaire-Buys D, Halaili E, Jean-Pastor MJ, Vespignan H, Coubes P, Crespel A. [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. Revue Neurologique. November 2007, 163 (11): 1096–9. PMID 18033049. doi:10.1016/s0035-3787(07)74183-8.
Sekar VJ, Spinosa-Guzman S, De Paepe E, De Pauw M, Vangeneugden T, Lefebvre E, Hoetelmans RM. Darunavir/ritonavir pharmacokinetics following coadministration with clarithromycin in healthy volunteers. Journal of Clinical Pharmacology. January 2008, 48 (1): 60–5. PMID 18094220. S2CID 38368595. doi:10.1177/0091270007309706.
Polis MA, Piscitelli SC, Vogel S, Witebsky FG, Conville PS, Petty B, Kovacs JA, Davey RT, Walker RE, Falloon J, Metcalf JA, Craft C, Lane HC, Masur H. Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. August 1997, 41 (8): 1709–14. PMC 163990 . PMID 9257746. doi:10.1128/AAC.41.8.1709.
Champney, W S; Tober, C L. Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. ntimicrobial Agents Chemotherapy. June, 1999, 43 (6): 1324–8 [2024-12-20]. doi:10.1128/AAC.43.6.1324. （原始内容存档于2025-01-23）. 请检查|date=中的日期值 (帮助)
Takahashi T, Noriaki S, Matsumura M, Li C, Takahashi K, Nishino S. Advances in pharmaceutical treatment options for narcolepsy. Expert Opinion on Orphan Drugs. 3 October 2018, 6 (10): 597–610. ISSN 2167-8707. doi:10.1080/21678707.2018.1521267.
Vieweg WV, Hancox JC, Hasnain M, Koneru JN, Gysel M, Baranchuk A. Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports. Therapeutic Advances in Infectious Disease. August 2013, 1 (4): 121–138. PMC 4040724 . PMID 25165548. doi:10.1177/2049936113497203.

drugs.com (Global: 399^th place; Chinese: 208^th place)

Clarithromycin. The American Society of Health-System Pharmacists. [2015-09-04]. （原始内容存档于2015-09-03）.
Clarithromycin Side Effects in Detail. Drugs.com. [2017-08-18]. （原始内容存档于2017-08-19）.

ed.ac.uk (Global: 1,871^st place; Chinese: 2,278^th place)

edrug.mvm.ed.ac.uk

Clarithromycin. eDrug. [2024-12-20]. （原始内容存档于2025-01-23）.

europa.eu (Global: 68^th place; Chinese: 209^th place)

ema.europa.eu

Active substance: clarithromycin (PDF). List of nationally authorised medicinal products. European Medicines Agency. 2020-12-10.

fda.gov (Global: 447^th place; Chinese: 581^st place)

accessdata.fda.gov

Biaxin Filmtab (clarithromycin tablets, USP) Biaxin XL Filmtab (clarithromycin extended-release tablets) Biaxin Granules (clarithromycin for oral suspension, USP) (PDF). 2015-11-02 [2015-11-02]. （原始内容存档 (PDF)于2015-08-24）.

fda.gov

Safety Alerts for Human Medical Products - Clarithromycin (Biaxin): Drug Safety Communication - Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease. U.S. Food and Drug Administration (FDA). [2018-02-24]. （原始内容存档于2018-04-24）.

handle.net (Global: 102^nd place; Chinese: 492^nd place)

hdl.handle.net

World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

mayoclinic.org (Global: 1,610^th place; Chinese: 2,275^th place)

Clarithromycin (oral route). Mayo Clinic. [2024-12-19]. （原始内容存档于2025-01-15）.

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Mommersteeg MC, Nieuwenburg SA, Wolters LM, Roovers BH, van Vuuren HA, Verhaar AP, Bruno MJ, Kuipers EJ, Peppelenbosch MP, Spaander MC, Fuhler GM. The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance.. United European Gastroenterol J. November 2023, 11 (9): e894–903. PMC 10637120 . PMID 37854002. doi:10.1002/ueg2.12473 .
Trotti LM, Becker LA, Friederich Murray C, Hoque R. Medications for daytime sleepiness in individuals with idiopathic hypersomnia. The Cochrane Database of Systematic Reviews. May 2021, 2021 (5): CD012714. PMC 8144933 . PMID 34031871. doi:10.1002/14651858.CD012714.pub2. There is insufficient evidence to conclude whether clarithromycin is effective for the treatment of idiopathic hypersomnia.
Maski K, Trotti LM, Kotagal S, Robert Auger R, Rowley JA, Hashmi SD, Watson NF. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. September 2021, 17 (9): 1881–1893. PMC 8636351 . PMID 34743789. doi:10.5664/jcsm.9328. Recommendation 9: We suggest that clinicians use clarithromycin (vs no treatment) for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL)
Winkel P, Hilden J, Fischer Hansen J, Hildebrandt P, Kastrup J, Kolmos HJ, Kjøller E, Jespersen CM, Gluud C, Jensen GB. Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?. Cardiology. 2011, 118 (1): 63–7. PMID 21447948. S2CID 11873791. doi:10.1159/000324533.
Tietz A, Heim MH, Eriksson U, Marsch S, Terracciano L, Krähenbühl S. Fulminant liver failure associated with clarithromycin. The Annals of Pharmacotherapy. January 2003, 37 (1): 57–60. PMID 12503933. doi:10.1345/1542-6270(2003)037<0057:flfawc>2.0.co;2.
Hougaard Christensen MM, Bruun Haastrup M, Øhlenschlaeger T, Esbech P, Arnspang Pedersen S, Bach Dunvald AC, Bjerregaard Stage T, Pilsgaard Henriksen D, Thestrup Pedersen AJ. Interaction potential between clarithromycin and individual statins-A systematic review. Basic Clin Pharmacol Toxicol. April 2020, 126 (4): 307–317. PMID 31628882. doi:10.1111/bcpt.13343.
Herdegen T, Cascorbi I. Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs: Recommendations for Clinical Practice. Dtsch Arztebl Int. December 2023, 120 (49): 833–840. PMC 10824494 . PMID 37874128. S2CID 264438050. doi:10.3238/arztebl.m2023.0223.
Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Annals of Internal Medicine. June 2013, 158 (12): 869–76. PMID 23778904. S2CID 21222679. doi:10.7326/0003-4819-158-12-201306180-00004.
Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, Garg AX. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. December 2013, 310 (23): 2544–53. PMID 24346990. doi:10.1001/jama.2013.282426.
Gélisse P, Hillaire-Buys D, Halaili E, Jean-Pastor MJ, Vespignan H, Coubes P, Crespel A. [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. Revue Neurologique. November 2007, 163 (11): 1096–9. PMID 18033049. doi:10.1016/s0035-3787(07)74183-8.
Sekar VJ, Spinosa-Guzman S, De Paepe E, De Pauw M, Vangeneugden T, Lefebvre E, Hoetelmans RM. Darunavir/ritonavir pharmacokinetics following coadministration with clarithromycin in healthy volunteers. Journal of Clinical Pharmacology. January 2008, 48 (1): 60–5. PMID 18094220. S2CID 38368595. doi:10.1177/0091270007309706.
Polis MA, Piscitelli SC, Vogel S, Witebsky FG, Conville PS, Petty B, Kovacs JA, Davey RT, Walker RE, Falloon J, Metcalf JA, Craft C, Lane HC, Masur H. Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. August 1997, 41 (8): 1709–14. PMC 163990 . PMID 9257746. doi:10.1128/AAC.41.8.1709.
Ferrero JL, Bopp BA, Marsh KC, Quigley SC, Johnson MJ, Anderson DJ, Lamm JE, Tolman KG, Sanders SW, Cavanaugh JH. Metabolism and disposition of clarithromycin in man. Drug Metabolism and Disposition. 1990, 18 (4): 441–6. PMID 1976065.
Vieweg WV, Hancox JC, Hasnain M, Koneru JN, Gysel M, Baranchuk A. Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports. Therapeutic Advances in Infectious Disease. August 2013, 1 (4): 121–138. PMC 4040724 . PMID 25165548. doi:10.1177/2049936113497203.

pubchem.ncbi.nlm.nih.gov

Clarithromycin. PunChen. [2024-12-19]. （原始内容存档于2025-02-06）.

pubmed.ncbi.nlm.nih.gov

Champney, W S; Tober, C L. Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. ntimicrobial Agents Chemotherapy. June, 1999, 43 (6): 1324–8 [2024-12-20]. doi:10.1128/AAC.43.6.1324. （原始内容存档于2025-01-23）. 请检查|date=中的日期值 (帮助)

semanticscholar.org (Global: 11^th place; Chinese: 332^nd place)

api.semanticscholar.org

Winkel P, Hilden J, Fischer Hansen J, Hildebrandt P, Kastrup J, Kolmos HJ, Kjøller E, Jespersen CM, Gluud C, Jensen GB. Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?. Cardiology. 2011, 118 (1): 63–7. PMID 21447948. S2CID 11873791. doi:10.1159/000324533.
Herdegen T, Cascorbi I. Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs: Recommendations for Clinical Practice. Dtsch Arztebl Int. December 2023, 120 (49): 833–840. PMC 10824494 . PMID 37874128. S2CID 264438050. doi:10.3238/arztebl.m2023.0223.
Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Annals of Internal Medicine. June 2013, 158 (12): 869–76. PMID 23778904. S2CID 21222679. doi:10.7326/0003-4819-158-12-201306180-00004.
Sekar VJ, Spinosa-Guzman S, De Paepe E, De Pauw M, Vangeneugden T, Lefebvre E, Hoetelmans RM. Darunavir/ritonavir pharmacokinetics following coadministration with clarithromycin in healthy volunteers. Journal of Clinical Pharmacology. January 2008, 48 (1): 60–5. PMID 18094220. S2CID 38368595. doi:10.1177/0091270007309706.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Clarithromycin. The American Society of Health-System Pharmacists. [2015-09-04]. （原始内容存档于2015-09-03）.
Greenwood D. Antimicrobial drugs : chronicle of a twentieth century medical triumph 1. Oxford: Oxford University Press. 2008: 239. ISBN 978-0-19-953484-5. （原始内容存档于2016-03-05）.
Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 498 [2025-01-06]. ISBN 978-3-527-60749-5. （原始内容存档于2024-09-29）.
Kirst HA. Macrolide Antibiotics 2. Basel: Birkhäuser Basel. 2012: 53. ISBN 978-3-0348-8105-0. （原始内容存档于2016-03-05）.
Clarithromycin. PunChen. [2024-12-19]. （原始内容存档于2025-02-06）.
Biaxin Filmtab (clarithromycin tablets, USP) Biaxin XL Filmtab (clarithromycin extended-release tablets) Biaxin Granules (clarithromycin for oral suspension, USP) (PDF). 2015-11-02 [2015-11-02]. （原始内容存档 (PDF)于2015-08-24）.
Treatment of Central Disorders of Hypersomnolence: An American Academy of Sleep Medicine Clinical Practice Guideline - Guidelines at a Glance (PDF). American Academy of Sleep Medicine. 2021 [2024-02-25]. （原始内容存档 (PDF)于2024-02-25）.
Clarithromycin (oral route). Mayo Clinic. [2024-12-19]. （原始内容存档于2025-01-15）.
Clarithromycin Side Effects in Detail. Drugs.com. [2017-08-18]. （原始内容存档于2017-08-19）.
Safety Alerts for Human Medical Products - Clarithromycin (Biaxin): Drug Safety Communication - Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease. U.S. Food and Drug Administration (FDA). [2018-02-24]. （原始内容存档于2018-04-24）.
Clarithromycin. eDrug. [2024-12-20]. （原始内容存档于2025-01-23）.
Champney, W S; Tober, C L. Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. ntimicrobial Agents Chemotherapy. June, 1999, 43 (6): 1324–8 [2024-12-20]. doi:10.1128/AAC.43.6.1324. （原始内容存档于2025-01-23）. 请检查|date=中的日期值 (帮助)

worldcat.org (Global: 5^th place; Chinese: 12^th place)

Takahashi T, Noriaki S, Matsumura M, Li C, Takahashi K, Nishino S. Advances in pharmaceutical treatment options for narcolepsy. Expert Opinion on Orphan Drugs. 3 October 2018, 6 (10): 597–610. ISSN 2167-8707. doi:10.1080/21678707.2018.1521267.

克拉黴素 (Chinese Wikipedia)

aasm.org (Global: low place; Chinese: low place)

archive.org (Global: 6th place; Chinese: 4th place)

books.google.com (Global: 3rd place; Chinese: 8th place)

doi.org (Global: 2nd place; Chinese: 23rd place)

drugs.com (Global: 399th place; Chinese: 208th place)

ed.ac.uk (Global: 1,871st place; Chinese: 2,278th place)